Go Pro

Adagene (ADAG) Financials

Adagene logo
$3.20 -0.17 (-5.04%)
Closing price 07/24/2026 04:00 PM Eastern
Extended Trading
$3.19 -0.01 (-0.31%)
As of 07/24/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Adagene

Annual Income Statements for Adagene

This table shows Adagene's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-14 -17 -43 -73 -80 -19 -33 -18
Consolidated Net Income / (Loss)
-15 -16 -42 -73 -80 -19 -33 -18
Net Income / (Loss) Continuing Operations
-15 -16 -42 -73 -80 -19 -33 -18
Total Pre-Tax Income
-15 -16 -42 -71 -80 -17 -33 -18
Total Operating Income
-17 -19 -43 -72 -84 -24 -36 -21
Total Gross Profit
-7.06 -10 -23 -45 9.29 18 0.10 7.67
Total Revenue
1.51 0.48 0.70 10 9.29 18 0.10 7.67
Operating Revenue
1.51 0.48 0.70 10 9.29 18 0.10 7.67
Total Cost of Revenue
8.58 11 24 55 0.00 0.00 0.00 0.00
Total Operating Expenses
10 9.14 20 28 93 42 36 29
Selling, General & Admin Expense
2.77 3.44 10 14 12 8.67 7.27 7.08
Research & Development Expense
7.50 5.70 9.89 13 81 37 29 22
Other Operating Expenses / (Income)
- - - 0.00 0.00 -3.48 0.00 0.00
Total Other Income / (Expense), net
2.07 2.74 0.75 0.89 4.41 6.46 2.51 3.53
Interest Expense
0.09 0.14 0.20 0.36 0.69 1.11 0.85 0.46
Interest & Investment Income
0.71 0.92 0.63 0.08 0.38 4.28 3.80 2.30
Other Income / (Expense), net
1.45 1.95 0.33 1.18 4.72 3.29 -0.44 1.69
Income Tax Expense
0.00 0.00 0.00 1.70 0.46 1.69 -0.02 -0.30
Basic Earnings per Share
($0.94) ($1.10) ($2.67) ($1.46) ($1.48) ($0.35) ($0.59) ($0.30)
Weighted Average Basic Shares Outstanding
15.16M 15.18M 15.95M 50.03M 54.14M 54.74M 56.29M 59.01M
Diluted Earnings per Share
($0.94) ($1.10) ($2.67) ($1.46) ($1.48) ($0.35) ($0.59) ($0.30)
Weighted Average Diluted Shares Outstanding
15.16M 15.18M 15.95M 50.03M 54.14M 54.74M 56.29M 59.01M
Weighted Average Basic & Diluted Shares Outstanding
- - 43.85M 54.60M 54.07M 55.15M 58.89M 59.23M

Quarterly Income Statements for Adagene

No quarterly income statements for Adagene are available.


Annual Cash Flow Statements for Adagene

This table details how cash moves in and out of Adagene's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
7.32 76 -17 99 -31 -34 -25 -11
Net Cash From Operating Activities
-14 -18 -29 -43 -49 -28 -30 -16
Net Cash From Continuing Operating Activities
-14 -18 -29 -43 -49 -28 -30 -16
Net Income / (Loss) Continuing Operations
-15 -16 -42 -73 -80 -19 -33 -18
Consolidated Net Income / (Loss)
-15 -16 -42 -73 -80 -19 -33 -18
Depreciation Expense
0.91 0.82 0.86 1.13 1.15 0.98 0.72 0.44
Amortization Expense
- - 0.00 0.00 0.30 0.23 0.22 0.15
Non-Cash Adjustments To Reconcile Net Income
1.71 -1.40 11 27 26 -12 1.15 2.76
Changes in Operating Assets and Liabilities, net
-1.62 -1.13 1.60 1.42 3.47 1.16 1.64 -1.40
Net Cash From Investing Activities
-30 25 7.07 -2.51 -0.69 -0.08 1.11 0.48
Net Cash From Continuing Investing Activities
-30 25 7.07 -2.51 -0.69 -0.08 1.11 0.48
Purchase of Property, Plant & Equipment
-0.51 -0.15 -0.94 -2.51 -0.69 -0.09 -0.03 -0.02
Purchase of Investments
-58 -19 - 0.00 0.00 -47 -129 -80
Sale of Property, Plant & Equipment
0.01 0.01 0.01 0.00 0.00 0.01 0.00 0.00
Sale and/or Maturity of Investments
29 44 8.00 0.00 0.00 47 130 80
Net Cash From Financing Activities
51 70 4.44 145 18 -5.37 3.77 4.45
Net Cash From Continuing Financing Activities
51 70 4.44 145 18 -5.37 3.77 4.45
Repayment of Debt
-1.36 -2.42 -1.06 -5.09 -4.35 -14 -8.34 -18
Issuance of Debt
2.42 2.65 6.08 4.39 26 8.13 4.92 5.64
Issuance of Preferred Equity
- - - - - 0.00 0.00 17
Issuance of Common Equity
- 0.00 0.00 149 0.00 0.00 7.33 0.00
Other Financing Activities, net
0.00 0.46 0.14 0.61 0.32 0.01 0.18 0.14
Effect of Exchange Rate Changes
0.04 0.08 -0.36 -0.19 0.84 0.07 0.08 0.06
Cash Interest Paid
0.09 0.14 0.20 0.36 0.60 1.05 0.78 0.40
Cash Income Taxes Paid
- - 0.00 0.00 2.43 1.38 0.03 0.00

Quarterly Cash Flow Statements for Adagene

No quarterly cash flow statements for Adagene are available.


Annual Balance Sheets for Adagene

This table presents Adagene's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
106 84 190 152 116 89 78
Total Current Assets
104 79 186 149 113 88 77
Cash & Equivalents
93 75 174 144 110 85 75
Note & Lease Receivable
- - - - - - 0.00
Accounts Receivable
1.91 0.13 7.51 0.62 0.22 0.01 0.02
Prepaid Expenses
1.48 3.81 4.06 4.94 3.29 2.58 2.83
Plant, Property, & Equipment, net
1.88 2.07 3.49 2.78 1.84 1.13 0.72
Total Noncurrent Assets
0.09 3.10 0.07 0.11 0.08 0.08 0.17
Other Noncurrent Operating Assets
- - - - - - 0.17
Total Liabilities & Shareholders' Equity
106 84 190 152 116 89 78
Total Liabilities
8.70 19 33 69 45 39 26
Total Current Liabilities
7.18 16 30 55 31 38 25
Short-Term Debt
1.04 5.02 4.50 14 8.40 18 4.98
Accounts Payable
2.61 4.35 14 3.67 3.09 4.24 2.88
Accrued Expenses
2.54 6.06 4.38 3.21 3.00 2.82 2.79
Current Deferred & Payable Income Tax Liabilities
- 0.00 1.66 0.00 0.05 0.01 0.41
Other Current Liabilities
0.99 0.73 5.50 34 17 13 14
Total Noncurrent Liabilities
1.52 3.06 3.13 14 14 0.42 1.19
Long-Term Debt
1.52 2.97 2.99 14 14 0.42 1.14
Other Noncurrent Operating Liabilities
- 0.09 0.09 0.03 - 0.00 0.05
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
154 154 - - - 0.00 17
Total Equity & Noncontrolling Interests
-57 -89 157 83 71 51 35
Total Preferred & Common Equity
-57 -89 157 83 71 51 35
Total Common Equity
-57 -89 157 83 71 51 35
Common Stock
6.79 24 336 343 350 362 366
Retained Earnings
-63 -106 -179 -259 -278 -311 -329
Accumulated Other Comprehensive Income / (Loss)
-0.34 -0.35 -0.09 -0.85 -1.80 -0.53 -1.91

Quarterly Balance Sheets for Adagene

No quarterly balance sheets for Adagene are available.


Annual Metrics And Ratios for Adagene

This table displays calculated financial ratios and metrics derived from Adagene's official financial filings.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
0.00 0.00 43,852,894.00 54,595,667.00 54,065,709.00 55,145,839.00 58,886,944.00 59,231,993.00
DEI Adjusted Shares Outstanding
0.00 0.00 43,852,894.00 54,595,667.00 54,065,709.00 55,145,839.00 58,886,944.00 59,231,993.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 0.00 -0.97 -1.34 -1.48 -0.34 -0.57 -0.30
Growth Metrics
- - - - - - - -
Revenue Growth
0.00% -68.24% 46.02% 1,351.71% -8.67% 94.90% -99.43% 7,332.76%
EBITDA Growth
0.00% -9.50% -155.89% -66.95% -10.97% 75.28% -84.44% 45.96%
EBIT Growth
0.00% -8.38% -148.73% -66.23% -11.25% 74.20% -78.12% 45.73%
NOPAT Growth
0.00% -10.59% -125.10% -67.70% -15.97% 71.74% -51.57% 40.37%
Net Income Growth
0.00% -7.64% -158.01% -72.60% -9.28% 76.31% -76.41% 47.32%
EPS Growth
0.00% -17.02% -142.73% 45.32% -1.37% 76.35% -68.57% 49.15%
Operating Cash Flow Growth
0.00% -27.26% -57.16% -52.17% -11.97% 41.47% -4.38% 47.28%
Free Cash Flow Firm Growth
0.00% 0.00% -106.20% -75.69% 20.45% 11.27% 18.52% 42.46%
Invested Capital Growth
0.00% 0.00% -496.96% -99.90% -216.91% 46.91% 5.57% 0.22%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - - - -
Gross Margin
-467.51% -2,089.05% -3,273.56% -440.73% 100.00% 100.00% 100.00% 100.00%
EBITDA Margin
-991.08% -3,416.71% -5,987.33% -688.57% -836.65% -106.13% -34,351.65% -249.75%
Operating Margin
-1,147.09% -3,993.68% -6,156.49% -711.18% -903.08% -130.97% -34,835.42% -279.48%
EBIT Margin
-1,051.23% -3,586.85% -6,109.80% -699.63% -852.25% -112.80% -35,261.36% -257.44%
Profit (Net Income) Margin
-1,010.22% -3,423.40% -6,048.86% -719.18% -860.59% -104.61% -32,386.45% -229.56%
Tax Burden Percent
100.00% 100.00% 100.00% 102.38% 100.58% 109.80% 99.95% 98.34%
Interest Burden Percent
96.10% 95.44% 99.00% 100.40% 100.40% 84.46% 91.90% 90.68%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
0.00% -16.91% -52.26% -66.04% -66.74% -24.66% -55.21% -34.39%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
0.00% -16.26% -45.04% -52.01% -46.33% -15.24% -35.50% -23.58%
Return on Assets (ROA)
0.00% -15.52% -44.59% -53.46% -46.78% -14.13% -32.61% -21.02%
Return on Common Equity (ROCE)
0.00% 9.92% 47.15% -20.20% -66.91% -24.66% -55.21% -28.83%
Return on Equity Simple (ROE_SIMPLE)
0.00% 28.82% 47.43% -46.74% -96.25% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-12 -13 -30 -51 -59 -17 -25 -15
NOPAT Margin
-802.97% -2,795.57% -4,309.54% -497.82% -632.16% -91.68% -24,384.79% -195.63%
Net Nonoperating Expense Percent (NNEP)
0.00% -6.15% -14.48% -18.99% -15.00% -2.29% -10.65% -3.84%
Return On Investment Capital (ROIC_SIMPLE)
- - - - -52.99% -17.95% -36.61% -36.19%
Cost of Revenue to Revenue
567.51% 2,189.05% 3,373.56% 540.73% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
182.98% 716.23% 1,471.59% 141.91% 127.78% 47.89% 7,047.53% 92.24%
R&D to Revenue
496.61% 1,188.40% 1,411.34% 128.54% 875.30% 202.30% 27,887.88% 287.24%
Operating Expenses to Revenue
679.59% 1,904.63% 2,882.93% 270.45% 1,003.08% 230.97% 34,935.42% 379.48%
Earnings before Interest and Taxes (EBIT)
-16 -17 -43 -71 -79 -20 -36 -20
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-15 -16 -42 -70 -78 -19 -35 -19
Valuation Ratios
- - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 1.80 0.70 1.18 1.74 2.52
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 1.80 0.70 1.18 1.74 2.52
Price to Revenue (P/Rev)
92.46 291.10 199.35 27.82 6.23 4.61 850.67 11.61
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 408.23 323.87 11.42 0.00 0.00 201.62 4.85
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - -
Debt to Equity
0.00 0.03 0.12 0.05 0.33 0.31 0.36 0.12
Long-Term Debt to Equity
0.00 0.02 0.05 0.02 0.17 0.19 0.01 0.02
Financial Leverage
0.00 -1.01 -1.04 -1.07 -1.18 -1.33 -1.28 -1.32
Leverage Ratio
0.00 1.09 1.17 1.24 1.43 1.75 1.69 1.64
Compound Leverage Factor
0.00 1.04 1.16 1.24 1.43 1.47 1.56 1.48
Debt to Total Capital
0.00% 2.56% 10.93% 4.57% 25.05% 23.72% 26.49% 10.54%
Short-Term Debt to Total Capital
0.00% 1.04% 6.87% 2.74% 12.29% 9.08% 25.89% 8.58%
Long-Term Debt to Total Capital
0.00% 1.52% 4.06% 1.82% 12.76% 14.64% 0.61% 1.96%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 154.59% 211.46% 0.00% 0.00% 0.00% 0.00% 28.53%
Common Equity to Total Capital
0.00% -57.15% -122.38% 95.81% 74.95% 76.28% 73.51% 60.93%
Debt to EBITDA
0.00 -0.16 -0.19 -0.11 -0.36 -1.14 -0.51 -0.32
Net Debt to EBITDA
0.00 5.97 1.60 2.38 1.49 4.58 1.89 3.57
Long-Term Debt to EBITDA
0.00 -0.09 -0.07 -0.04 -0.18 -0.70 -0.01 -0.06
Debt to NOPAT
0.00 -0.19 -0.26 -0.15 -0.47 -1.32 -0.72 -0.41
Net Debt to NOPAT
0.00 7.30 2.22 3.29 1.97 5.30 2.66 4.56
Long-Term Debt to NOPAT
0.00 -0.11 -0.10 -0.06 -0.24 -0.82 -0.02 -0.08
Altman Z-Score
0.00 9.37 1.84 3.64 -2.79 -1.83 -4.20 -3.79
Noncontrolling Interest Sharing Ratio
0.00% 158.66% 190.23% 69.41% -0.26% 0.00% 0.00% 16.16%
Liquidity Ratios
- - - - - - - -
Current Ratio
0.00 14.47 4.90 6.24 2.71 3.61 2.30 3.07
Quick Ratio
0.00 14.27 4.66 6.10 2.62 3.50 2.23 2.96
Cash Flow Metrics
- - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -13 -26 -45 -36 -32 -26 -15
Operating Cash Flow to CapEx
-2,799.53% -12,595.09% -3,076.75% -1,729.72% -7,085.78% -36,784.27% -88,895.83% -100,028.43%
Free Cash Flow to Firm to Interest Expense
0.00 -90.85 -127.96 -124.95 -52.15 -28.96 -30.69 -32.48
Operating Cash Flow to Interest Expense
-156.61 -131.46 -141.12 -119.35 -70.11 -25.69 -34.87 -33.81
Operating Cash Flow Less CapEx to Interest Expense
-162.20 -132.50 -145.71 -126.25 -71.10 -25.76 -34.90 -33.84
Efficiency Ratios
- - - - - - - -
Asset Turnover
0.00 0.00 0.01 0.07 0.05 0.14 0.00 0.09
Accounts Receivable Turnover
0.00 0.25 0.69 2.66 2.29 43.05 0.90 597.93
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.26 0.36 3.66 2.96 7.84 0.07 8.33
Accounts Payable Turnover
0.00 4.03 6.80 6.07 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
0.00 1,454.82 532.62 137.01 159.59 8.48 407.31 0.61
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 90.61 53.67 60.15 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
0.00 1,364.21 478.95 76.87 159.59 8.48 407.31 0.61
Capital & Investment Metrics
- - - - - - - -
Invested Capital
0.00 -0.87 -5.21 -10 -33 -18 -17 -17
Invested Capital Turnover
0.00 -1.10 -0.23 -1.30 -0.43 -0.72 -0.01 -0.46
Increase / (Decrease) in Invested Capital
0.00 -0.87 -4.34 -5.20 -23 15 0.98 0.04
Enterprise Value (EV)
0.00 196 227 116 -58 -4.46 21 37
Market Capitalization
140 140 140 283 58 84 88 89
Book Value per Share
$0.00 ($3.76) ($5.60) $3.58 $1.52 $1.31 $0.92 $0.60
Tangible Book Value per Share
$0.00 ($3.76) ($5.60) $3.58 $1.52 $1.31 $0.92 $0.60
Total Capital
0.00 100 73 164 111 92 69 58
Total Debt
0.00 2.56 7.98 7.49 28 22 18 6.12
Total Long-Term Debt
0.00 1.52 2.97 2.99 14 14 0.42 1.14
Net Debt
0.00 -98 -67 -167 -116 -88 -67 -68
Capital Expenditures (CapEx)
0.51 0.14 0.93 2.51 0.69 0.08 0.03 0.02
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -2.75 -7.18 -14 -36 -20 -18 -17
Debt-free Net Working Capital (DFNWC)
0.00 98 68 161 108 90 67 57
Net Working Capital (NWC)
0.00 97 63 156 94 82 50 52
Net Nonoperating Expense (NNE)
3.13 3.01 12 23 21 2.34 8.26 2.60
Net Nonoperating Obligations (NNO)
0.00 -98 -70 -167 -116 -88 -67 -68
Total Depreciation and Amortization (D&A)
0.91 0.82 0.86 1.13 1.45 1.21 0.94 0.59
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -573.31% -1,024.95% -135.25% -386.38% -107.94% -17,256.00% -226.06%
Debt-free Net Working Capital to Revenue
0.00% 20,371.02% 9,696.93% 1,578.63% 1,160.63% 499.05% 65,293.61% 745.45%
Net Working Capital to Revenue
0.00% 20,154.51% 8,981.37% 1,534.43% 1,014.07% 452.69% 48,053.43% 680.53%
Earnings Adjustments
- - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($2.67) ($1.46) ($1.48) ($0.35) ($0.59) ($0.30)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 15.95M 50.03M 54.14M 54.74M 56.29M 59.01M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($2.67) ($1.46) ($1.48) ($0.35) ($0.59) ($0.30)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 15.95M 50.03M 54.14M 54.74M 56.29M 59.01M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 43.85M 54.60M 54.07M 55.15M 58.89M 59.23M
Normalized Net Operating Profit after Tax (NOPAT)
-12 -13 -30 -51 -59 -17 -25 -15
Normalized NOPAT Margin
-802.97% -2,795.57% -4,309.54% -497.82% -632.16% -91.68% -24,384.79% -195.63%
Pre Tax Income Margin
-1,010.22% -3,423.40% -6,048.86% -702.45% -855.65% -95.27% -32,403.46% -233.44%
Debt Service Ratios
- - - - - - - -
EBIT to Interest Expense
-174.41 -124.67 -211.83 -195.70 -114.23 -18.44 -42.72 -42.64
NOPAT to Interest Expense
-133.22 -97.17 -149.41 -139.25 -84.73 -14.99 -29.54 -32.40
EBIT Less CapEx to Interest Expense
-180.00 -125.72 -216.42 -202.60 -115.22 -18.51 -42.76 -42.67
NOPAT Less CapEx to Interest Expense
-138.81 -98.21 -154.00 -146.15 -85.72 -15.06 -29.58 -32.44
Payout Ratios
- - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% -1.70% -5.42% -4.97% 0.00% -0.94% 0.00%

Quarterly Metrics And Ratios for Adagene

No quarterly metrics and ratios for Adagene are available.



Financials Breakdown Chart

Adagene Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Adagene's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

In the past 7 years, Adagene's net income has ranged from -$79.97 million in 2022 to -$15.27 million in 2018, and is currently -$17.61 million as of their latest financial filing in 2025. Check out Adagene's forecast to explore projected trends and price targets.

Adagene's total operating income in 2025 was -$21.44 million, based on the following breakdown:
  • Total Gross Profit: $7.67 million
  • Total Operating Expenses: $29.11 million

Over the last 7 years, Adagene's total revenue changed from $1.51 million in 2018 to $7.67 million in 2025, a change of 407.6%.

Adagene's total liabilities were at $26.36 million at the end of 2025, a 32.0% decrease from 2024, and a 203.1% increase since 2019.

In the past 6 years, Adagene's cash and equivalents has ranged from $74.52 million in 2025 to $174.39 million in 2021, and is currently $74.52 million as of their latest financial filing in 2025.

Over the last 7 years, Adagene's book value per share changed from 0.00 in 2018 to 0.60 in 2025, a change of 60.0%.



Financial statements for NASDAQ:ADAG last updated on 7/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners